- Home
- KRMD vs ADAG Comparison
KRMD vs ADAG Comparison
Compare KRMD & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- ADAG
- Stock Information
- Founded
- KRMD 1980
- ADAG 2011
- Country
- KRMD United States
- ADAG China
- Employees
- KRMD N/A
- ADAG 174
- Industry
- KRMD Medical/Dental Instruments
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- KRMD Health Care
- ADAG Health Care
- Exchange
- KRMD Nasdaq
- ADAG Nasdaq
- Market Cap
- KRMD 127.0M
- ADAG 100.5M
- IPO Year
- KRMD N/A
- ADAG 2021
- Fundamental
- Price
- KRMD $2.64
- ADAG $2.21
- Analyst Decision
- KRMD Strong Buy
- ADAG Strong Buy
- Analyst Count
- KRMD 3
- ADAG 1
- Target Price
- KRMD $3.33
- ADAG $5.00
- AVG Volume (30 Days)
- KRMD 108.2K
- ADAG 94.6K
- Earning Date
- KRMD 11-06-2024
- ADAG 07-25-2024
- Dividend Yield
- KRMD N/A
- ADAG N/A
- EPS Growth
- KRMD N/A
- ADAG N/A
- EPS
- KRMD N/A
- ADAG N/A
- Revenue
- KRMD $30,817,017.00
- ADAG $815,746.00
- Revenue This Year
- KRMD $15.46
- ADAG N/A
- Revenue Next Year
- KRMD $17.47
- ADAG $2.70
- P/E Ratio
- KRMD N/A
- ADAG N/A
- Revenue Growth
- KRMD 4.70
- ADAG N/A
- 52 Week Low
- KRMD $1.98
- ADAG $1.30
- 52 Week High
- KRMD $3.09
- ADAG $4.38
- Technical
- Relative Strength Index (RSI)
- KRMD 54.05
- ADAG 42.53
- Support Level
- KRMD $2.46
- ADAG $2.10
- Resistance Level
- KRMD $2.74
- ADAG $2.41
- Average True Range (ATR)
- KRMD 0.16
- ADAG 0.30
- MACD
- KRMD -0.00
- ADAG -0.02
- Stochastic Oscillator
- KRMD 45.71
- ADAG 37.27
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About ADAG Adagene Inc.
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.